In summary, the evidence from the analysis of prostate cancer cell lines, transgenic mice and clinical samples support the role of the BCL-2 family proteins in apoptosis regulation in the prostate epithelium, yet our knowledge of specifics is limited. This evidence concerns the gene BCL2 and prostate cancer.